TRENTON – The Senate Commerce Committee advanced legislation sponsored by Senators Troy Singleton and Brian Stack that would expand health insurance coverage for prostate cancer screenings and require that these services be provided without cost-sharing for eligible patients.

The bill, S-1796, would require health insurers to cover an annual prostate cancer screening in accordance with the latest nationally recognized clinical practice guidelines, ensuring that screening recommendations evolve alongside the most current medical evidence.

“Early detection can make all the difference when it comes to successfully treating prostate cancer,” said Senator Troy Singleton (D-Burlington). “By eliminating financial barriers to screening and ensuring that coverage aligns with the most up-to-date clinical guidelines, we can help more men receive timely diagnoses and lifesaving treatment.”

Under the legislation, prostate cancer screenings would be covered without deductibles, copayments, coinsurance, or other cost-sharing requirements. The bill applies broadly across health insurance markets, including individual and group plans, hospital and medical service corporations, health maintenance organizations, and plans offered through the State Health Benefits Program and the School Employees’ Health Benefits Program.

The measure also ensures that coverage requirements extend to high-deductible health plans to the maximum extent permitted under federal law, while preserving eligibility for health savings accounts and medical savings accounts.

“Prostate cancer remains one of the most common cancers, affecting one in eight men during their lifetime,” said Senator Brian Stack (D-Hudson). “When detected early, it is often highly treatable. Ensuring that screening is covered without out-of-pocket costs and guided by the latest medical standards will help more men get tested and detect the disease earlier, when treatment is most effective.”

The legislation defines nationally recognized clinical practice guidelines as evidence-based recommendations developed by independent medical organizations or professional societies that rely on systematic review of scientific evidence and transparent conflict-of-interest policies.

Nine states and the District of Columbia have enacted similar laws eliminating cost-sharing requirements for prostate cancer screening services.

The bill would take effect 90 days after enactment and apply to health insurance policies issued or renewed after that date.